Advancing the science of vision
For ophthalmic surgeons and clinics seeking predictable refractive outcomes and reliable support, AST VisionCare delivers intraocular lens solutions designed for consistent real-world performance.
35 years of science shaping the future of vision
Advanced biomaterials. Precision optics. Surgical performance.
- 35+ years at the forefront of biocompatible materials and medical-grade coatings for ophthalmology.
- A multidisciplinary team of physicists, chemists and biomaterials engineers, transforming scientific research into surgical solutions.
- The Asqelio™ IOL platform — convergence of scientific innovation, precision engineering and clinical application, delivering predictable outcomes and long-term safety.
- In 2019, the AST VisionCare surgical division brought this expertise directly to surgeons worldwide.
- 1989Biocompatible materials & medical-grade coatings for ophthalmology
- 2017Asqelio™ — our bi-aspheric intraocular lens platform
- 2019AST VisionCare surgical division established
What guides us
AST's values define how we think, act and communicate — operational, not aspirational. They guide decisions across science, design, communication and partnerships, ensuring consistency, credibility and long-term trust.
Scientific integrity
All claims and communications are grounded in evidence and traceability.
Product quality
Precision in materials, optics and manufacturing drives reliable outcomes.
Customer centricity
Decisions are made with surgeons, teams and patients in mind.
What we offer
Intraocular lens solutions, surgical support and traceable clinical evidence — delivered as a long-term partnership beyond the procedure.
What we deliver
- Intraocular lens solutions for modern cataract and refractive needs.
- Practical surgical support and training.
- Clinical evidence and communication aligned with robust, traceable clinical data.
- Long-term partnership beyond the initial procedure.
Reasons to believe
-
Research-driven, bi-aspheric lens
Designed to support predictability and optical quality.
-
Biomaterials & medical-grade coatings expertise
Built on decades of research and development.
-
Fully integrated, 100% in-house
End-to-end control across design, engineering, manufacturing and clinical support.
Our commitments
We align our priorities with the UN Sustainable Development Goals and build every Asqelio™ lens to the EU Medical Device Regulation.
SustainabilityAligned with the UN SDGs
SDG icons are the property of the United Nations; shown for reference.
Quality & regulatoryWhat the MDR means for us
The EU Medical Device Regulation (MDR 2017/745) sets a rigorous framework for the safety, performance and traceability of medical devices — every Asqelio™ lens is built to meet it.
-
CE-marked to MDR
CE mark under MDR 2017/745 with complete technical documentation.
-
Clinical evaluation
Backed by structured clinical evaluation and peer-reviewed evidence.
-
Post-market surveillance
Ongoing monitoring and full traceability through the device lifecycle.
Where we are
Headquartered in Billerica, Massachusetts, with distribution partners serving markets worldwide.
